| Typicality: | 0.356 |
| Saliency: | 0.250 |
| further | 5 | purpose |
| in therapeutics | 2 | other |
| invention → contemplate → the use | 5 |
| invention → contemplate → use | 5 |
| invention → contemplate → the possibility | 4 |
| invention → contemplate for → example | 3 |
| invention → contemplate → the like | 3 |
| negative | neutral | positive |
| 0.047 | 0.792 | 0.160 |
| Raw frequency | 20 |
| Normalized frequency | 0.250 |
| Modifier score | 0.500 |
| Perplexity | 110.223 |